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The LIM domain-binding protein Ldb1 is an essential cofactor of LIM-homeodomain (LIM-HD) and LIM-only
(LMO) proteins in development. The stoichiometry of Ldb1, LIM-HD, and LMO proteins is tightly controlled
in the cell and is likely a critical determinant of their biological actions. Single-stranded DNA-binding
proteins (SSBPs) were recently shown to interact with Ldb1 and are also important in developmental
programs. We establish here that two mammalian SSBPs, SSBP2 and SSBP3, contribute to an erythroid
DNA-binding complex that contains the transcription factors Tal1 and GATA-1, the LIM domain protein
Lmo2, and Ldb1 and binds a bipartite E-box-GATA DNA sequence motif. In addition, SSBP2 was found to
augment transcription of the Protein 4.2 (P4.2) gene, a direct target of the E-box-GATA-binding complex, in an
Ldb1-dependent manner and to increase endogenous Ldb1 and Lmo2 protein levels, E-box-GATA DNA-binding
activity, and P4.2 and -globin expression in erythroid progenitors. Finally, SSBP2 was demonstrated to
inhibit Ldb1 and Lmo2 interaction with the E3 ubiquitin ligase RLIM, prevent RLIM-mediated Ldb1
ubiquitination, and protect Ldb1 and Lmo2 from proteasomal degradation. These results define a novel
biochemical function for SSBPs in regulating the abundance of LIM domain and LIM domain-binding proteins.
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The LIM domain-binding protein Ldb1 was originally
identified through its interaction with LIM-homeodo-
main (LIM-HD) and LIM-only (LMO) proteins (Agulnick
et al. 1996; Jurata et al. 1996; Bach et al. 1997; Visvader
et al. 1997), and these interactions are critical for Ldb1
function (Agulnick et al. 1996; Bach et al. 1997; Jurata
and Gill 1997; Morcillo et al. 1997; Cassata et al. 2000;
van Meyel et al. 2000; Thaler et al. 2002; Pueyo and
Couso 2004; Nishioka et al. 2005). Ldb1 is required for
normal development as evidenced by the severe defects
in Ldb1-null mice, including the absence of primitive
hematopoiesis (Mukhopadhyay et al. 2003). These and
other studies have established that this LIM protein co-
factor participates in diverse developmental programs
(Matthews and Visvader 2003).
The relative abundance of Ldb1, LIM-HD, and LMO
proteins is critical to formation of the multiprotein com-
plexes to which they contribute and, ultimately, their
biological actions (Fernández-Fúnez et al. 1998; Milán
and Cohen 1999; van Meyel et al. 1999, 2000; Rincón-
Limas et al. 2000). Proper stoichiometry of Drosophila
Ldb1 (or Chip) and Apterous, a LIM-HD protein with
which Chip interacts, is essential for the formation and
function of this complex (van Meyel et al. 2000), and
Ldb1 also contributes to DNA-binding complexes con-
taining LIM-only proteins, GATA transcription factors,
and basic helix–loop–helix (bHLH) protein heterodimers
(Visvader et al. 1997; Wadman et al. 1997; Heitzler et al.
2003; Xu et al. 2003). While genetic studies have pro-
vided insight into Ldb1’s biological functions, little is
known about how the levels of Ldb1 and its LIM protein
interaction partners are controlled in cells or how assem-
bly of Ldb1-containing transcriptional complexes is
regulated.
The RING finger protein RLIM encoded by the RNF12
gene acts as an E3 ubiquitin ligase for Ldb1, LMO2, and
7Corresponding author.
E-MAIL stephen.brandt@vanderbilt.edu; FAX (615) 936-2929.
Article is online at http://www.genesdev.org/cgi/doi/10.1101/gad.1528507.
942 GENES & DEVELOPMENT 21:942–955 © 2007 by Cold Spring Harbor Laboratory Press ISSN 0890-9369/07; www.genesdev.org
histone deacetylase HDAC2, with the ubiquitinated
forms of these proteins flagged for destruction in the 26S
proteasome (Ostendorff et al. 2002; Hiratani et al. 2003;
Krämer et al. 2003). Transient increases in the LIM-only
protein LMO2 or LIM-HD protein Xlim-1 were shown to
inhibit RLIM-mediated turnover of Ldb1, suggesting its
LIM protein partners regulate Ldb1 levels in vivo (Osten-
dorff et al. 2002; Hiratani et al. 2003). However, LMO2 is
also a substrate of RLIM (Ostendorff et al. 2002; Hiratani
et al. 2003), dLMO protein expression in the Drosophila
wing requires Chip rather than the reverse (Milán and
Cohen 2000), and Xlim-1 levels do not correlate with
those of Ldb1 (Hiratani et al. 2003). Thus, the specific
contribution LIM domain proteins make to Ldb1 protein
stability has been unclear.
CSDP, the founding member of a group of single-
stranded DNA-binding proteins, was isolated through its
single-stranded DNA-binding activity (Bayarsaihan and
Lukens 1996), while the closely related single-stranded
DNA-binding protein 2 (SSBP2) was discovered as a tar-
get of an unbalanced translocation in myeloid leukemia
cells (Castro et al. 2002). The SSBPs have been widely
studied as Ldb1 interaction partners, and there is consid-
erable genetic evidence for their function in axis forma-
tion in Xenopus, wing development in Drosophila, and
head morphogenesis in mice (Chen et al. 2002; van
Meyel et al. 2003; Nishioka et al. 2005; Enkhmandakh et
al. 2006). Both dSsdp and murine Ssbp3 have been shown
to be essential for normal embryonic development (Chen
et al. 2002; van Meyel et al. 2003; Nishioka et al. 2005;
Enkhmandakh et al. 2006). While the physical and func-
tional interactions between SSBPs and Ldb1 predict that
these proteins contribute to common transcriptional com-
plexes (Chen et al. 2002; van Meyel et al. 2003; Nishioka et
al. 2005), the precise composition of such complexes, the
target genes they regulate, and the actions of SSBPs in com-
plex formation or function are not known.
We recently showed that the Protein 4.2 (P4.2) gene is
a target of a DNA-binding complex in proerythroblasts
that includes the transcription factors TAL1 (also known
as SCL), E47, GATA-1, LMO2, and Ldb1 and determined
that Ldb1 plays a positive role in erythroid gene expres-
sion and differentiation (Xu et al. 2003). We establish
here that two SSBPs, Ssbp2 and Ssbp3, are associated
with this DNA-binding complex and that Ssbp2 occupies
and augments transcription from the P4.2 promoter in
murine erythroid cells. Furthermore, SSBP2 was demon-
strated to inhibit RLIM-mediated ubiquitination and
proteasomal destruction of Ldb1 and inhibit Lmo2 turn-
over via a mechanism requiring Ldb1. These data define
a novel biochemical function for the SSBPs that accounts
for their Ldb1-dependent actions in development.
Results
Ssbp2 and Ssbp3 are integral components
of an erythroid E-box-GATA DNA-binding complex
We and others have described a DNA-binding complex
in erythroid cells that contains TAL1, GATA-1, Ldb1,
and Lmo2 and binds an E-box-GATA sequence element
(Wadman et al. 1997; Xu et al. 2003), and we established
that the P4.2 gene promoter is one of its physiologic
targets (Xu et al. 2003). To identify other members of this
multiprotein complex, we undertook both candidate pro-
tein and protein purification approaches. Given the re-
ports of SSBP interaction with Ldb1 (Chen et al. 2002;
van Meyel et al. 2003), we investigated whether mem-
bers of this class of proteins were components of the
complex, initially through antibody supershift analysis.
As described (Xu et al. 2003), incubation of extracts of
both murine erythroleukemia (MEL) cells and splenic
proerythroblasts elicited by the anemia-inducing stain of
Friend virus (FVA cells) with a 32P-labeled E-box-GATA
oligonucleotide corresponding to an E-box-GATA ele-
ment in the P4.2 promoter led to formation of two highly
retarded protein–DNA complexes (Fig. 1A, arrowheads).
The more retarded, and less abundant, of these appears to
contain two protein–DNA complexes linked in solution
by Ldb1 and the faster a single protein–DNA complex
(Xu et al. 2003). Both complexes were supershifted by
incubating extracts with antibodies to two of its known
components, GATA-1 and Ldb1 (Fig. 1A; Wadman et al.
1997; Xu et al. 2003). Furthermore, rabbit polyclonal an-
tibody to Ssbp2 (asterisk in Fig. 1A [lanes 4,9], B [lane 4])
and to Ssbp3 (Fig. 1B, lane 3), but not normal rabbit IgG
(Fig. 1A [lanes 5,10], Fig. 1B [lane 5]) also supershifted
both complexes. The Ssbp2 and Ssbp3 antibodies had no
effect, in contrast, on a less retarded protein–DNA com-
plex (filled circles in Fig. 1A [lanes 4,9], B [lanes 3,4])
supershifted exclusively by antibody to GATA-1 (Fig.
1A, lanes 2,7). Additionally, mass spectrometry analysis
of proteins that copurified with a tandem epitope (TAP)-
tagged Tal1 protein in MEL cells (Y. Cai, Z. Xu, J. Xie,
M.J. Koury, S.W. Hiebert, and S.J. Brandt, in prep.) re-
vealed multiple peptides derived from both Ssbp2 and
Ssbp3 (see Supplemental Material). Finally, chromatin
immunoprecipitation (ChIP) analysis showed that anti-
bodies to Ssbp2 and Ldb1, but not normal rabbit IgG,
precipitated chromatin fragments from the P4.2 pro-
moter (Fig. 1C), establishing that Ssbp2 occupies this
promoter with Ldb1 in cells. These results demonstrate
that Ssbp2 and Ssbp3 are components of the TAL1- and
GATA-1-containing complex(es) in erythroid progeni-
tors. While not excluding the possibility that individual
complexes could contain only one of these two SSBPs,
supershift analysis suggests that most complexes con-
tain both Ssbp2 and Ssbp3.
To evaluate the contribution of the SSBPs to P4.2 pro-
moter function, a P4.2 promoter-luciferase reporter and
expression vector for SSBP2 were transfected into COS-
7L cells with different combinations of plasmids for the
five previously described components of the complex.
Expression of SSBP2 with TAL1, E47, GATA-1, LMO2,
and Ldb1 effected a nearly 50-fold increase in reporter
activity compared with the 25-fold induction observed in
its absence (Fig. 1D, cf. lanes 5 and 4), representing an
approximately twofold increase in activity specifically
attributable to SSBP2. Transfection of SSBP2 alone, in
contrast, had no effect on reporter activity (Fig. 1D, cf.
lanes 2 and 1), indicating that SSBP2 must be recruited to
SSBPs regulate LMO and Ldb1 protein levels
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DNA, by the E-box-GATA DNA-binding complex(es) at
this promoter, to activate transcription. A deletion mu-
tant, SSBP2(95–261), lacking a major portion of SSBP2’s
Gly–Pro-rich central domain was significantly impaired
in transactivating activity (Fig. 1D, cf. lanes 6 and 5),
while the SSBP2(51–94) deletion mutant lacking half of
the N-terminal LUFS domain and thus incapable of bind-
ing to Ldb1 (van Meyel et al. 2003) was completely in-
active (Fig. 1D, cf. lanes 7 and 4). Likewise, no further
increase in reporter activity was obtained with full-
length SSBP2 in the absence of Ldb1 (Fig. 1D, cf. lanes 8
and 4), and SSBP2 had little to no effect on reporter ac-
tivity when cotransfected with Ldb1(214–223), a dele-
tion mutant lacking part of the Ldb1/Chip conserved do-
main (LCCD) and impaired in SSBP2 interaction (Fig.
1D, cf. lanes 11 and 10; van Meyel et al. 2003). This Ldb1
mutant exhibited the same transactivating activity as
wild-type Ldb1, in contrast, when transfected with the
core components of this complex in the absence of
SSBP2 (Fig. 1D, cf. lanes 10 and 4). Finally, when the
Lmo2 expression plasmid was left out, reporter activity
was reduced to the level observed with Tal1, E47, and
GATA-1 (Fig. 1D, cf. lanes 9 and 3), presumably from the
inability of the ternary complex to form in the absence of
Lmo2 (Wadman et al. 1997; Xu et al. 2003).
To determine whether SSBP2 activated transcription
in a more physiological cellular environment, expression
plasmids for SSBP2 or a short-hairpin RNA (shRNA) tar-
geted to Ssbp2 were transfected with the P4.2 promoter-
luciferase reporter into differentiating MEL cells. Deple-
tion of Ssbp2 by RNA interference (RNAi) decreased (Fig.
1E) while enforced expression of SSBP2 increased (Fig.
1F) reporter activity, both in a concentration-dependent
manner. Finally, cotransfection of SSBP2 and Ldb1 into
differentiating MEL cells converted overexpressed Ldb1
from an inhibitor to an activator of reporter activity (Fig.
1G, cf. lanes 4 and 3). This effect was attenuated when a
truncation mutant of SSBP2 was used (Fig. 1G, cf. lanes
6 and 4) and abrogated with deletion of the LUFS domain
of SSBP2 (Fig. 1G, cf. lanes 8 and 4) or LCCD of Ldb1 (Fig.
1G, cf. lanes 10 and 4). These results indicate that SSBP2
is an integral component of the E-box-GATA DNA-bind-
ing complex and that it promotes transcription from the
P4.2 promoter in an Ldb1-dependent manner. Moreover,
Figure 1. Ssbp2 and Ssbp3 are integral
components of an erythroid E-box-GATA
DNA-binding complex. (A) EMSA of
nuclear extracts from MEL and FVA cells
for E-box-GATA DNA-binding activity.
Rabbit IgG or antibodies to GATA-1, Ldb1,
or SSBP2 were used as indicated for super-
shift analysis. Complexes supershifted by
antibodies to GATA-1 and Ldb1 are
marked with solid arrowheads and com-
plexes containing only GATA-1 are
marked with filled circles. Complexes su-
pershifted by SSBP2 antibody are marked
to the right of the relevant lane with aster-
isks. (B) EMSA of nuclear extracts from
MEL cells for E-box-GATA DNA-binding
activity. Normal rabbit IgG or antibodies
to SSBP3 and SSBP2 were used for super-
shift analysis and DNA-binding complexes
marked as above. (C) ChIP analysis of
SSBP2 and Ldb1 occupancy at the P4.2 pro-
moter in differentiating MEL cells. (D)
Transient transfection analysis with a plas-
mid (1.4 µg) containing 1.7 kb of the P4.2
promoter linked to a luciferase reporter
gene in COS-7L cells transfected with
(filled column) or without (unfilled col-
umn) indicated combinations of expres-
sion plasmids pcDNA3.1-Tal1 (100 ng),
pcDNA3.1-E47 (3 ng), pcDNA3.1-GATA-1
(25 ng), pEFIRES-Ldb1 (40 ng), pEFIRES-
Ldb1(214–223) (40 ng), pEFIRES-Lmo2 (40
ng), pEFIRES-SSBP2 (200 ng), pEFIRES-
SSBP2(95–261) (200 ng), and pEFIRES-
SSBP2(51–94) (200 ng). The mean ± SEM
luciferase activity relative to that with re-
porter alone from three independent experiments is plotted. Reporter analysis in DMSO-treated MEL cells transfected with (filled
column) or without (unfilled column) indicated amounts of pSilencer-Ssbp2-B (E), pEFIRES-SSBP2 (F), and indicated combinations of
pEFIRES-SSBP2 (500 ng), pEFIRES-SSBP2(95–261) (500 ng), pEFIRES-SSBP2(51–94) (500 ng), pEFIRES-Ldb1 (500 ng), and pEFIRES-
Ldb1(214–223) (500 ng) (G).
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they suggest that SSBP2 levels in MEL cells could be
limiting for complex activity.
SSBP2 positively regulates P4.2 and -globin gene
expression in erythroid progenitors
To examine whether SSBP2 regulates endogenous P4.2
gene expression in erythroid cells, Flag-tagged SSBP2 and
the SSBP2(95–261) mutant lacking the protein’s puta-
tive single-stranded DNA-binding domain were ex-
pressed in MEL cells. Western blot analysis of two poly-
clonal populations of transduced cells using antibodies
to the Flag epitope and to SSBP2 showed that while
transfected Flag-tagged SSBP2(95–261) protein was
readily detected (Fig. 2A), Flag-tagged full-length SSBP2
protein was not (data not shown). Because SSBP2 can
potentially inhibit cellular proliferation (Liang et al.
2005), causing selection against overexpressing cells in a
mixed population, oligoclonal lines of SSBP2-transduced
MEL cells were derived and analyzed. As shown in Fig-
ure 2A, unambiguous expression of transduced SSBP2
protein was detected in three of these lines using anti-
bodies to the Flag epitope and SSBP2.
While vector-transduced cells were pale, pellets of
cells transduced with SSBP2 and SSBP2(95–261) ap-
peared pink, even in the absence of an inducer of ery-
throid differentiation, prompting us to investigate the
effect of these proteins on erythroid gene expression.
Quantitative RT–PCR analysis showed that overexpres-
sion of these proteins similarly, and markedly, increased
P4.2 and -globin mRNA levels without affecting RLIM
gene expression (Fig. 2B). These results suggest that
SSBP2 is a positive regulator of gene transcription in ery-
throid progenitors.
Overexpression of SSBP2 increases assembly
of the E-box-GATA DNA-binding complex in vitro
and P4.2 promoter occupancy in vivo
To elucidate the mechanism by which SSBPs regulate
erythroid gene expression, we began by examining the
expression pattern of Ssbp2 and Ssbp3 in MEL cells in-
duced to differentiate with dimethyl sulfoxide (DMSO).
Ssbp2 protein levels progressively increased over the first
2 d after addition of the inducer and then declined (Fig.
3A, top panel), with Ssbp3 protein levels showing a
slightly earlier increase (Fig. 3A, bottom panel). As their
abundance paralleled that of E-box-GATA DNA-binding
activity during MEL-cell differentiation (Xu et al. 2003),
we investigated whether the SSBPs had a role in complex
formation or stability through use of nuclear extracts
from MEL cells engineered to overexpress SSBP2. Over-
expression of SSBP2 significantly increased the levels of
the less retarded, and more abundant, of the two DNA-
binding complexes (Fig. 3B, cf. lanes 2–4 and 1,6, solid
arrowhead), and enforced expression of SSBP2(95–261)
did the same (Fig. 3B, cf. lanes 5 and 1,6, gray arrowhead).
Supershift analysis confirmed the incorporation of Flag-
tagged SSBP2 and Flag-tagged SSBP2(95–261), as well as
Ldb1 and GATA-1 proteins, into this complex (Fig.
3C,D). This E-box-GATA-binding complex had slightly
greater mobility in SSBP2(95–261)- than in SSBP2-
transduced cells, due either to the smaller size of the
SSBP2(95–261) protein or the absence of proteins re-
cruited by full-length SSBP2 but not SSBP2(95–261). For
reasons unclear at present, enforced expression of SSBP2
or SSBP2(95–261) did not alter the more retarded of the
two DNA-binding complexes (Fig. 3B, open arrowhead).
In sum, overexpression of SSBP2 significantly stimulated
the assembly of a DNA-binding complex to which this
protein contributes.
To investigate whether the increase in DNA-binding
activity in SSBP2-transduced cells translated into in-
creased occupancy of the P4.2 promoter, quantitative
ChIP analysis was carried out. Overexpression of SSBP2
increased its loading on the P4.2 promoter (Fig. 3E, top
panel), and, consistent with the increase in E-box-GATA
DNA-binding activity detected by electrophoretic mo-
bility shift analysis (EMSA) (Fig. 3B), also increased Ldb1
and GATA-1 recruitment (Fig. 3E, top panel). In contrast,
these proteins did not occupy the 3 untranslated region
(3 UTR) of this gene at significant levels, with or with-
out SSBP2 overexpression (Fig. 3E, bottom panel).
Finally, the effect of SSBP2 on DNA-binding activity
was determined in the presence and absence of Ldb1 and
Lmo2. To that end, 5 µg of nuclear extracts of COS-7L
cells transfected with different combinations of expres-
sion plasmids were mixed with 5 µg of nuclear extracts
of undifferentiated MEL cells, and E-box-GATA DNA-
binding activity was assayed. As shown in Figure 3F,
addition of transfected SSBP2, either with or without
Figure 2. SSBP2 positively regulates P4.2 and -globin gene
expression in MEL cells. (A) Western blot analysis of Flag-tagged
SSBP2 and SSBP2(95–261) mutant in MEL whole cellular ex-
tracts with antibody to the Flag epitope (top) and nuclear ex-
tracts with antibody to amino acids 269–284 of SSBP2 (bottom).
A cross-reacting protein recognized by Flag antibody is marked
with an asterisk and served as loading control. (B) Quantitative
RT–PCR analysis of P4.2, -globin, and RLIM mRNAs in indi-
cated MEL cell transductants. The mean ± SEM RNA level rela-
tive to vector control is plotted.
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Ldb1, modestly increased the abundance of the lower
E-box-GATA DNA-binding complex (Fig. 3F, cf. lanes
2,4 and 1, solid arrowhead). The greatest increase in
DNA-binding activity, however, was observed with bal-
anced overexpression of SSBP2, Ldb1, and Lmo2 (Fig. 3F,
cf. lanes 7 and 1). As in MEL cells transduced with SSBP2
(Fig. 3B), the amount of the upper complex did not
change with provision of SSBP2 protein in vitro (Fig. 3F,
lanes 2,4,7, open arrowhead). These results show that
maximal assembly of this ternary complex required the
simultaneous expression of SSBP2, Ldb1, and Lmo2 in
cells.
Ssbp2 regulates the abundance of Ldb1 and Lmo2
proteins in erythroid progenitors
To gain insight into how SSBP2 stimulated complex as-
sembly, the protein levels of the known components of
the complex were determined. As shown in Figure 4A,
Figure 3. Overexpression of SSBP2 increases E-box-GATA
DNA-binding activity and P4.2 promoter occupancy in MEL
cells. (A) Western blot analysis of Ssbp2 (top) and Ssbp3 (bottom)
protein expression in whole cellular extracts of differentiating
MEL cells at times after DMSO addition. Actin was used as
loading control. (B) EMSA of E-box-GATA DNA-binding activ-
ity in nuclear extracts from SSBP2-transduced MEL cells. The
upper ternary complex is marked with an open arrowhead, and
the lower complex, whose abundance was stimulated by SSBP2
overexpression, is marked with a solid arrowhead. The levels of
DNA-binding activity for the lower complex were normalized
to a nonspecific protein–DNA complex (asterisk). The fold
change relative to vector control is shown below the autoradio-
graphs. Antibody supershift analysis of nuclear extracts from
oligoclonal population O4 transduced with full-length SSBP2
(C) or a polyclonal population transduced with SSBP2(95–261)
(D) using antibodies to Flag epitope, Ldb1, and GATA-1. DNA-
binding complexes are marked as above. (E) Quantitative ChIP
analysis of factor occupancy at the promoter or 3 UTR of the
P4.2 gene for vector-transduced (unfilled column) and SSBP2-
transduced (filled column) MEL cells. The mean ± SEM occu-
pancy as a percentage of input for SSBP2, Ldb1, and GATA-1 is
plotted. (F) EMSA of E-box-GATA DNA-binding activity using
nuclear extracts (5 µg) from COS-7L cells transfected with in-
dicated combinations of pEFIRES-SSBP2, pEFIRES-Ldb1, and
pEFIRES-Lmo2, assayed as mixed with nuclear extract (5 µg)
from undifferentiated MEL cells. The levels of DNA-binding
activity of the lower complex were normalized as above. The
fold change relative to vector control is shown below the auto-
radiographs.
Figure 4. SSBP2 regulates the abundance of Ldb1 and Lmo2
proteins. (A) Western blot analysis of Tal1, GATA-1, Hdac2,
Ldb1, and Lmo2 abundance in nuclear extracts from transduced
MEL cells. The levels of Ldb1 and Lmo2 in SSBP2- or
SSBP2(95–261)-transduced cells relative to vector control are
shown below the autoradiographs. (B) Western blot analysis of
endogenous Ldb1 and Hdac2 expression and transduced Flag-
tagged SSBP2 protein expression in COS-7L and CHO cells tran-
siently transfected with increasing amounts of pEFIRES-SSBP2
(175 ng, 525 ng, and 1.6 µg for COS-7L cells; 125 ng and 1.0 µg
for CHO cells). (C) Quantitative RT–PCR analysis of Ldb1 ex-
pression in indicated MEL cell transductants. The mean ± SEM
RNA level relative to that in vector control is plotted. (D) Pro-
tein turnover analysis in SSBP2-transduced MEL cells treated
with 100 µM CHX for the indicated times. (Top) Ldb1 expres-
sion was detected by Western blot analysis and quantified by
densitometry of X-ray films. (Bottom) The amount of protein
remaining is expressed as a function of time from addition of
CHX.
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oligoclonal populations overexpressing full-length
SSBP2 and polyclonal populations expressing SSBP2(95–
261) contained significantly greater amounts of Ldb1 and
Lmo2 without any change in the abundance of Tal1,
GATA-1, or an irrelevant protein, Hdac2. Transient
overexpression of SSBP2 in both COS-7L and CHO cells
also caused a concentration-dependent increase in en-
dogenous Ldb1 levels, again without an effect on Hdac2
(Fig. 4B). Finally, quantitative RT–PCR analysis showed
that Ldb1 mRNA was not altered in SSBP2- or SSBP2(95–
261)-transduced MEL cells (Fig. 4C), while studies using
the protein synthesis inhibitor cycloheximide (CHX) re-
vealed a marked decrease in Ldb1 protein turnover in
SSBP2-overexpressing cells (Fig. 4D). Specifically, the
half-life of Ldb1 was ∼2 h in the vector control cells and
>4 h in SSBP2-transduced cells (Fig. 4D). These data
show that SSBP2 positively regulates Ldb1 and Lmo2
protein levels in differentiating erythroid progenitors.
Depletion of Ssbp2 and Ssbp3 by RNAi reduces
the abundance of Ldb1 and Lmo2 in erythroid
progenitors
To determine whether Ssbp2 and Ssbp3 are required for
Ldb1 and Lmo2 protein accumulation, shRNAs targeted
to Ssbp2 and/or Ssbp3 were expressed in MEL cells. As
shown in Figure 5A, knockdown of Ssbp2 expression in
independent clonal populations of transduced MEL cells
treated with 1.5% DMSO for 2 d to induce differentia-
tion significantly reduced steady-state levels of Ldb1 and
Lmo2 proteins without affecting Hdac2 levels (see the
Supplemental Material for results with an additional
clone). Likewise, transient expression of Ssbp2 shRNA
in differentiating MEL cells significantly reduced Ssbp2,
P4.2, and -globin mRNA levels without affecting Ssbp3
or Rlim gene expression (Fig. 5B), and depletion of Ssbp3
by shRNA also markedly decreased steady-state levels of
Ldb1 and Lmo2 (Fig. 5C). Furthermore, as shown in Fig-
ure 5D, the decline in Ssbp3 protein levels in shRNA-
transduced cells was associated with a significant reduc-
tion in E-box-GATA DNA-binding activity (Fig. 5D,
solid arrowhead) but not in a binding activity attribut-
able to GATA-1 alone (Fig. 5D, filled circle). Finally, si-
multaneous depletion of Ssbp2 and Ssbp3 by specific
shRNAs caused an even greater reduction in Ldb1 and
Lmo2 abundance (Fig. 5E), E-box-GATA DNA-binding
activity (Fig. 5F), and P4.2 and -globin mRNA levels,
again without affecting Rlim gene expression (Fig. 5G).
Together, these studies indicate that at the concentra-
tions prevailing in differentiating erythroid progenitors,
Ssbp2 and Ssbp3 actively control the levels of Ldb1 and
Lmo2 protein and E-box-GATA DNA-binding activity.
SSBP2 prevents RLIM-mediated degradation of Ldb1,
Lmo2, and LMO4 proteins
Since RLIM was reported to accelerate Ldb1 and Lmo2
destruction (Ostendorff et al. 2002; Hiratani et al. 2003),
we investigated whether the SSBPs increased the abun-
dance of these proteins through inhibition of RLIM ac-
tion. To examine Ldb1 and Lmo2 protein levels simul-
taneously, their coding sequences were cloned in-frame
with sequences encoding the V5 epitope, and V5-tagged
Ldb1 and Lmo2 were expressed in CHO cells with RLIM
and Flag-tagged SSBP2. The levels of Ldb1 and Lmo2
Figure 5. Depletion of Ssbp2 and Ssbp3 reduces Ldb1 and
Lmo2 abundance and E-box-GATA DNA-binding activity. (A)
Western blot analysis of Ssbp2, Ldb1, Lmo2, and Hdac2 expres-
sion in whole cellular extracts from Ssbp2 shRNA-transduced
MEL cells treated with 1.5% DMSO for 2 d. The levels of pro-
teins in cells expressing Ssbp2 shRNA relative to those express-
ing a control shRNA are shown below the autoradiographs. (B)
Quantitative RT–PCR analysis of Ssbp2, Ssbp3, P4.2, -globin,
and Rlim mRNAs in differentiating MEL cells transiently trans-
fected with expression plasmid for Ssbp2 shRNA or control
shRNA. (C) Western blot analysis of Ssbp3, Ldb1, Lmo2, Ssbp2,
Hdac2, and GATA-1 expression in nuclear extracts from short-
term puromycin-selected MEL cells transfected with expression
plasmid for Ssbp3 shRNA or control shRNA. (D) EMSA of
nuclear extracts prepared as above. The E-box-GATA DNA-
binding complex is marked with a solid arrowhead. Its abun-
dance was normalized to that of a nonspecific protein–DNA
complex (asterisk). The fold change in E-box-GATA DNA-bind-
ing activity in cells expressing Ssbp3 shRNA relative to those
expressing control shRNA is shown below the autoradiographs.
(E) Western blot analysis of Ssbp3, Ssbp2, Ldb1, Lmo2, Hdac2,
and GATA-1 abundance in nuclear extracts from short-term
puromycin-selected MEL cells expressing shRNAs to both
Ssbp2 and Ssbp3 or control (EGFP) shRNA. (F) EMSA of nuclear
extracts prepared as above. Protein–DNA complexes are marked
as in D. (G) Quantitative RT–PCR analysis of P4.2, -globin,
and Rlim mRNAs in differentiating MEL cells transfected with
shRNA expression plasmids for Ssbp2 and Ssbp3 or a control
sequence (EGFP).
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were then determined by Western blot analysis using an
antibody to the V5 epitope tag.
Confirming its reported role in Ldb1 degradation,
RLIM expression markedly decreased Ldb1 protein levels
(Fig. 6A, top panel, cf. lanes 3 and 2). Enforced expression
of SSBP2 effected a concentration-dependent inhibition
of RLIM-mediated Ldb1 degradation (Fig. 6A, top panel,
cf. lanes 4–6 and 3) and increased Ldb1 expression to a
level even greater than what was observed without RLIM
transfection (Fig. 6A, top panel, cf. lanes 4–6 and 2),
likely reflecting the actions of overexpressed SSBP2 on
both transfected and endogenous RLIM (Ostendorff et al.
2002). While RLIM also promoted degradation of
Ldb1(214–223) (Fig. 6A, top panel, cf. lanes 8 and 7),
SSBP2 did not protect this LCCD mutant (Fig. 6A, top
panel, cf. lanes 9 and 8), suggesting that SSBP2 inhibition
of RLIM-mediated degradation requires its direct inter-
action with Ldb1. In addition to Ldb1, SSBP2 also spared
Lmo2 from RLIM-mediated destruction (Fig. 6B, top
panel, cf. lanes 3 and 2). These actions of SSBP2 were not
observed, however, when Ldb1(214–223) was trans-
fected in place of Ldb1 (Fig. 6B, top panel, cf. lanes 6 and
5) or Ldb1 was not transfected at all (Fig. 6B, top panel, cf.
lanes 9 and 8). As shown earlier, overexpressed SSBP2
had no effect on the abundance of Hdac2, which is a
substrate of RLIM but does not interact with Ldb1 (Fig.
4A,B). These results suggest that SSBP2 inhibition of
RLIM-promoted destruction of Ldb1 and Lmo2 requires
its physical interaction with Ldb1.
Next, the domains in SSBP2 important for its Lmo2
and Ldb1 protein-sparing effects were determined. While
wild-type SSBP2 protected Ldb1 and Lmo2 from RLIM-
mediated degradation in a concentration-dependent
manner (Fig. 6C, top panel, cf. lanes 3–5 and 2),
SSBP2(51–94) had no effect on Ldb1 protein abundance
(Fig. 6C, top panel, cf. lanes 7 and 2) at any level. In
contrast, both SSBP2(95–261) and SSBP2(1–94) pro-
tected Ldb1 from degradation in a manner similar to full-
length SSBP2 (Fig. 6C, top panel, cf. lanes 6,8 and 2).
These results demonstrate that its LUFS, or Ldb1 inter-
action, domain is necessary and sufficient for SSBP2 in-
hibition of RLIM-mediated Ldb1 and Lmo2 turnover.
To investigate whether SSBP2-mediated protection of
Lmo2 from degradation requires Lmo2–Ldb1 interaction,
we took advantage of a naturally occurring Ldb1 splice
isoform, Ldb1b, that retains the protein’s dimerization
domain and LCCD but lacks its LIM interaction domain
(LID) (Tran et al. 2006). Similar to what was observed for
Figure 6. SSBP2 prevents RLIM-mediated degradation of Ldb1 and Lmo2 proteins. (A) Western blot analysis of CHO cells transfected
with indicated combinations of pTracer-EF/V5-Ldb1 (400 ng), pTracer-EF/V5-Ldb1(214–223) (400 ng), pCMV6-XL4-RLIM (1.2 µg), and
pEFIRES-SSBP2 (100, 200, or 400 ng). The total mass of DNA was adjusted to 2 µg with plasmid pCMV4 as needed. Whole cellular
extracts were prepared 48 h after transfection and assayed for protein expression using a monoclonal antibody to the V5 epitope and
polyclonal antibody to the Flag epitope. A cross-reacting protein recognized by the Flag antibody is marked with an asterisk and served
as loading control. (B) Western blot analysis of CHO cells transfected with indicated combinations of pTracer-EF/V5-Ldb1 (300 ng),
pTracer-EF/V5-Ldb1(214–223) (300 ng), pTracer-EF/V5-Lmo2 (500 ng), pCMV6-XL4-RLIM (800 ng), and pEFIRES-SSBP2 (400 ng). V5-
and Flag-tagged proteins were detected as above. (C) Western blot analysis of CHO cells transfected with indicated combinations of
pTracer-EF/V5-Ldb1 (300 ng), pTracer-EF/V5-Lmo2 (500 ng), pCMV6-XL4-RLIM (800 ng), pEFIRES-SSBP2 (100, 200, or 400 ng),
pEFIRES-SSBP2(95–261) (400 ng), SSBP2(51–94) (400 ng), and SSBP2(1–94) (400 ng). (D) Western blot analysis of CHO cells trans-
fected as above using indicated combinations of pTracer-EF/V5-Ldb1b (300 ng), pTracer-EF/V5-Lmo2 (500 ng), pTracer-EF/V5-RLIM
(800 ng), and pEFIRES-SSBP2 (400 ng). (E) Western blot analysis of CHO cells transfected as in C with pTracer-EF/V5-LMO4 instead
of pTracer-EF/V5-Lmo2.
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wild-type Ldb1 (Fig. 6A–C), enforced RLIM expression
decreased the abundance of Ldb1b (Fig. 6D, top panel, cf.
lanes 2 and 1), and SSBP2 protected Ldb1b from RLIM-
initiated degradation (Fig. 6D, top panel, cf. lanes 3 and
2). In contrast to full-length Ldb1, however, Ldb1b did
not cooperate with SSBP2 in protecting Lmo2 from
RLIM-promoted degradation (Fig. 6D, middle panel, cf.
lanes 3 and 2). Finally, no effect of overexpressed SSBP2
was observed on RLIM protein levels (Fig. 6D, middle
panel, cf. lanes 3 and 2), indicating that SSBP2 did not act
by reducing RLIM abundance. These studies suggest that
direct interaction with Ldb1 is essential for SSBP2 to
protect this LIM-only protein from degradation.
The four LMO proteins, which are each important de-
velopmental regulators (de la Calle-Mustienes et al.
2003; Gering et al. 2003; Lee et al. 2005), share consid-
erable sequence homology and the ability to interact
with Ldb1, prompting us to investigate whether SSBP2
regulated the abundance of any LIM-only protein besides
LMO2, and LMO4, the most divergent member of this
protein family, was selected for analysis. Similar to the
results with Lmo2 (Fig. 6B,C), RLIM expression de-
creased (Fig. 6E, top panel, cf. lanes 2 and 1) while en-
forced expression of SSBP2 or SSBP2(1–94) dramatically
increased LMO4 protein levels (Fig. 6E, top panel, cf.
lanes 3,4 and 1). Furthermore, this effect of SSBP2 was
not observed with the Ldb1 LCCD deletion mutant (Fig.
6E, top panel, cf. lanes 7 and 6). These studies indicate
that SSBP2 is capable of protecting multiple LMO pro-
teins from RLIM-initiated degradation.
SSBP2 inhibits RLIM-mediated ubiquitination of Ldb1
by preventing RLIM interaction with Ldb1
The E3 ubiquitin ligase RLIM catalyzes the ubiquitina-
tion of its substrates, targeting them for destruction in
the proteasome (Ostendorff et al. 2002; Hiratani et al.
2003). We therefore examined whether SSBP2 inhibited
RLIM-promoted ubiquitination of Ldb1. To that end, an
expression plasmid for Ldb1 was transfected into CHO
cells with plasmids encoding RLIM, SSBP2, and/or HA-
tagged ubiquitin, and total cellular extracts of trans-
fected cells were subjected to coimmunoprecipitation
analysis. While ubiquitination of Ldb1 was detected in
CHO cells not transfected with RLIM (Fig. 7A, top and
middle panels, lane 1), likely reflecting endogenous ubiq-
uitin ligase activity, ubiquitination was markedly in-
creased in RLIM-transfected cells (Fig. 7A, top and
Figure 7. SSBP2 inhibits RLIM-mediated Ldb1 ubiquitination and RLIM interaction with Ldb1. (A) Western blot analysis of CHO
cells transfected with indicated combinations of pEFIRES-Ldb1 (400 ng), pCMV6-XL4-RLIM (1.0 µg), pEFIRES-SSBP2 (300 ng),
pEFIRES-SSBP2(1–94) (300 ng), and CMV-HA-ubiquitin (300 ng). Whole cellular extracts prepared from MG132-treated transfectants
were subjected to coimmunoprecipitation analysis as indicated. (B) Lack of deubiquitinating activity of SSBP2. Equivalent amounts of
ubiquitinated Ldb1 immobilized on beads were incubated with or without purified Flag-SSBP2 protein. Ubiquitinated Ldb1 and
Flag-SSBP2 retained on beads were then quantified by Western blot analysis. (C) Western blot analysis of CHO cells transfected as
above with indicated combinations of pEFIRES-Ldb1 (500 ng), pTracer-EF/V5-Lmo2 (500 ng), pTracer-EF/V5-RLIM (500 ng), pEFIRES-
SSBP2 (500 ng), and pEFIRES-SSBP2(1–94) (500 ng). Whole cellular extracts from MG132-treated transfectants were subjected to
coimmunoprecipitation analysis as indicated. Western blot analysis of SSBP2, Ldb1, and Lmo2 in purified SSBP2 protein complexes
was carried out following denaturing (D) and nondenaturing (E) polyacrylamide gel electrophoresis. CHO cells were transfected with
expression plasmids for Ldb1, Lmo2, and Flag-tagged SSBP2, and Western blot analysis of SSBP2-associated proteins was carried out
on purified complexes following elution with Flag peptide.
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middle panels, cf. lanes 2 and 1). In turn, expression of
either SSBP2 or SSBP2(1–94) reduced RLIM-initiated
Ldb1 ubiquitination to a level even lower than in the
absence of transfected RLIM (Fig. 7A, top panel, cf. lanes
3,5 and 1), with inhibition of Ldb1 ubiquitination by
SSBP2 correlating with higher steady-state levels of Ldb1
protein (Fig. 7A, bottom panel, cf. lanes 3,5 and 2). In
control experiments, Ldb1 ubiquitination was not de-
tected when HA-tagged ubiquitin was not transfected
(Fig. 7A, top and middle panels, lane 4). These results
establish that SSBP2 inhibits RLIM-mediated Ldb1 ubiq-
uitination.
To exclude the possibility of SSBP2 having deubiqui-
tinating activity (Amerik and Hochstrasser 2004), which
could explain both the protein stability and ubiquitina-
tion results, purified SSBP2 protein was incubated with
ubiquitinated Ldb1 under conditions optimal for deubiq-
uitinating enzyme activity (Li et al. 2002). Although
SSBP2 physically associated with ubiquitinated Ldb1
(Fig. 7B, bottom panel), it did not alter the extent of Ldb1
ubiquitination (Fig. 7B, top panel), indicating that SSBP2
lacks deubiquitinase function.
A member of the RING family of E3 ubiquitin ligases,
RLIM must interact with its substrates to effect the
transfer of ubiquitin from an E2 ubiquitin-conjugating
enzyme (Pickart 2001). The affinity of Ldb1 for RLIM
was therefore investigated in the presence and absence of
SSBP2. Without transfected SSBP2, both RLIM and Lmo2
were immunoprecipitated by an antibody to Ldb1 (Fig.
7C, top panel, lane 1), indicating that an interaction ex-
isted between RLIM and Ldb1 in these cells. Enforced
expression of SSBP2 or SSBP2(1–94) markedly decreased
Ldb1’s association with RLIM without affecting its in-
teraction with Lmo2 (Fig. 7C, top panel, cf. lanes 2,4 and
1). However, neither RLIM nor Lmo2 was immunopre-
cipitated by an antibody to Ldb1 when Ldb1 was not also
transfected (Fig. 7C, top panel, lane 3), indicating the
specificity of this coimmunoprecipitation analysis. Con-
firming published information, its LUFS domain was
sufficient for SSBP2 interaction with Ldb1 (Fig. 7C, sec-
ond panel, lanes 2,4).
Although these studies are consistent with SSBP2 in-
hibiting RLIM–Ldb1 interaction through direct binding
to Ldb1, they would also be compatible with SSBP2 bind-
ing first to RLIM and preventing its interaction with
Ldb1. To distinguish between these possibilities, anti-
body to the Flag epitope was used in coimmunoprecipi-
tation analysis of SSBP2 and associated proteins. RLIM
was not immunoprecipitated by Flag antibody in either
the presence or absence of Ldb1 (Fig. 7C, the third panel
from the top, lanes 2,4), demonstrating that SSBP2 did
not act through direct interaction with RLIM. In con-
trast, Lmo2 was associated with SSBP2 and SSBP2(1–94)
in the presence of Ldb1 (Fig. 7C, third panel, lanes 2,4)
but not its absence (Fig. 7C, third panel, lane 3), support-
ing the notion that Ldb1 contacts SSBP2 and Lmo2 si-
multaneously through its separate SSBP- and LIM-inter-
acting domains. The exclusion of RLIM from this trimo-
lecular complex suggests, furthermore, that while
capable of interacting with Ldb1 and Lmo2 in the ab-
sence of SSBP2, RLIM is not able to contact these pro-
teins when they are complexed with SSBP2. These re-
sults suggest that SSBP2 binding prevents Ldb1 and
LMO2 from encountering RLIM and in this way inhibits
their ubiquitination.
To gain further evidence that SSBP2, Ldb1, and Lmo2
contribute to a common complex, an expression vector
encoding Flag-tagged SSBP2 was transfected into CHO
cells with plasmids for Ldb1 and Lmo2. SSBP2 and asso-
ciated proteins were immunoprecipitated from trans-
fected cells using antibody to the Flag epitope and then
eluted from the agarose beads with Flag peptide. Western
blot analysis of these purified SSBP2 protein complexes
showed that SSBP2, Ldb1, and Lmo2 were each present
(Fig. 7D), with SSBP2, Ldb1, and Lmo2 comigrating in a
single high-molecular-weight complex when gels were
run under nondenaturing conditions (Fig. 7E). These re-
sults demonstrate that SSBP2 forms a stable trimolecular
complex with Ldb1 and Lmo2 in cells.
Discussion
Although the importance of SSBPs in development is
well established (Chen et al. 2002; van Meyel et al. 2003;
Nishioka et al. 2005; Enkhmandakh et al. 2006), the spe-
cific genes they regulate have not been determined. We
show here that both Ssbp2 and Ssbp3 contribute to a
multiprotein complex binding the proximal promoter of
the P4.2 gene and that Ssbp2 augments P4.2 transcrip-
tion and occupies this promoter with previously identi-
fied components of the complex. Given the direct inter-
action of SSBPs with Ldb1 (Chen et al. 2002; van Meyel
et al. 2003) and the requirement of Ldb1 for multiple
functions of LIM-HD, LMO, and even non-LIM proteins
(Agulnick et al. 1996; Morcillo et al. 1997; van Meyel et
al. 2000; Weihe et al. 2001; Nishioka et al. 2005), the
SSBPs likely regulate a broader range of developmental
processes than presently appreciated (Chen et al. 2002;
van Meyel et al. 2003; Nishioka et al. 2005; Enkhman-
dakh et al. 2006).
Genetic experiments have emphasized the Ldb1 de-
pendence of SSBP action, particularly in developmental
processes (Chen et al. 2002; van Meyel et al. 2003; Nish-
ioka et al. 2005). Using the P4.2 E-box-GATA DNA-
binding complex as a model, we confirmed the impor-
tance of this interaction, and the involvement of the
LCCD and LUFS domain of Ldb1 and SSBP2, for Ldb1’s
contribution to SSBP2 function. Given the evolutionary
conservation of these two protein interaction domains
(Chen et al. 2002; van Meyel et al. 2003) and the ability
of every SSBP examined to interact with Ldb1 (Chen et
al. 2002; van Meyel et al. 2003), all members of this
protein family are likely able to protect all LDB isoforms
from degradation. In support is the reduction in Ldb1
protein abundance observed in erythroid cells in which
Ssbp2 and Ssbp3 expression was knocked down by RNA
interference and in a mouse pituitary cell line in which
Ssbp3 was similarly depleted (Y. Cai, Z. Xu, and S.J.
Brandt, unpubl.). In addition to reducing Ldb1 turnover,
SSBP2 also protected Lmo2 from RLIM-promoted degra-
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dation. While SSBP2 does not interact with LIM-only
proteins directly, it was found to contribute to a complex
containing both Lmo2 and Ldb1. That RLIM was ex-
cluded from this complex suggests that SSBP2 prevents
this ubiquitin ligase from encountering its substrates.
SSBP binding may mask Ldb1’s RLIM interaction do-
main or elicit a conformational change that achieves the
same result, with SSBP2-bound Ldb1 likely acting simi-
larly for LMO2. Such a mechanism (Fig. 8) is highly
reminiscent of how TAF(II)31 enhances the stability of
p53 (Buschmann et al. 2001).
The LIM interaction domain of Ldb1, like its LCCD,
has been highly conserved in evolution. This region me-
diates Ldb1 interaction with both LIM-HD and LIM-only
proteins (Jurata et al. 1996), and the effect of SSBPs on
LMO protein turnover probably extends to many if not
most LIM proteins capable of binding Ldb1. If correct,
this would explain the requirement of Drosophila Ldb1
(Chip) in both dLMO (Milán and Cohen 2000) and Apter-
ous (Weihe et al. 2001) protein expression in the devel-
oping wing and the dose-sparing effect of Drosophila
Ssdp and mouse Ssbp3 on enhancement of axis induction
by Ldb1 and Xlim-1 in Xenopus embryos (Chen et al.
2002). Our studies predict, furthermore, that at compa-
rable expression levels, dLMO would be stabilized by
dSsdp to a greater extent than Apterous as a result of its
greater affinity for Chip (Weihe et al. 2001).
Although SSBP2 might enhance the transactivating
function of the E-box-GATA DNA-binding complex (Fig.
1D; Nishioka et al. 2005; Wu 2006), it also appeared to
promote complex assembly (Fig. 3B,F). Ssbp2 and Ssbp3
concentrations may, in fact, be limiting for complex for-
mation, a conclusion supported by the increase in E-box-
GATA DNA-binding activity with SSBP2 overexpres-
sion and decrease with Ssbp3 depletion. While the in-
creased abundance of Ldb1 and Lmo2 could itself
increase DNA-binding activity, the SSBP/Ldb1/Lmo2
trimolecular complex may also help nucleate or stabilize
the larger DNA-binding complex.
The results of supershift analysis showing that anti-
body to Ssbp2 largely and to Ssbp3 completely shifted
the E-box-GATA-binding complexes suggest that both
Ssbp2 and Ssbp3 are present in the majority of com-
plexes. If the erythroid E-box-GATA DNA-binding com-
plex contains an Ldb1 homodimer as proposed by Rab-
bitts and colleagues (Wadman et al. 1997), each Ldb1
molecule in this dimer could simultaneously contact
one molecule of Ssbp2 or Ssbp3 and one molecule of
Lmo2 through its separate LCCD and LIM interaction
domain (Fig. 8). This predicts that the relative concen-
trations of the SSBP orthologs would dictate their incor-
poration. In support, proteomic and/or antibody super-
shift analyses of Tal1- and Ldb1-containing complexes in
MEL cells, which express comparable levels of Ssbp2 and
Ssbp3, identified both SSBPs (Goardon et al. 2006; Meier
et al. 2006), whereas only Ssbp3 was detected in an Lhx2-
and Ldb1-containing DNA-binding complex from a pitu-
itary cell line that expresses considerably more Ssbp3
than Ssbp2 (Y. Cai, Z. Xu, and S.J. Brandt, unpubl.). Fi-
nally, while the N-terminal LUFS domains of the SSBPs
are virtually identical, their internal amino acid se-
quences, including a potential activation domain in
Ssbp3 (Wu 2006), diverge. It is therefore possible that
certain SSBPs possess functions not shared with other
family members, a notion supported by the finding that
SSBP2, but not SSBP3, interacts with the adenoviral on-
coprotein E1B55K (Fleisig et al. 2007).
From the results of both overexpression and knock-
down studies, we propose that Ldb1 levels are regulated
in cells by a dynamic equilibrium between the SSBPs
acting to protect Ldb1 from ubiquitination and specific
E3 ubiquitin ligases, including RLIM (Ostendorff et al.
2002; Hiratani et al. 2003) and possibly RNF6 (Hiratani
et al. 2003) promoting Ldb1 ubiquitination. The reduc-
tion in Ldb1 levels in cells in which Ssbp2 and Ssbp3
were knocked down (see above) or the Ssbp2 gene had
been knocked out (Y. Yang and L. Nagarajan, unpubl.)
and the severe disruptions in head development in mice
with reduced Ssbp3 expression owing to a transgene in-
Figure 8. Model of SSBP regulation of Ldb1 and LMO protein
stability and transcriptional complex assembly. Top shows
schematic of mouse Ldb1 with dimerization domain (DD),
Ldb1/Chip conserved domain (LCCD), and LIM interaction do-
main (LID) marked. The model predicts that when at sufficient
levels, SSBPs interact with Ldb1 to promote formation of an
SSBP/Ldb1/LMO trimolecular complex, with Ldb1 contacting
SSBP and Lmo2 simultaneously through its separate LCCD and
LID, respectively. This prevents their interaction with the ubiq-
uitin ligase RLIM, RLIM-initiated ubiquitination, and protea-
somal degradation. The SSBP/Ldb1/LMO complex could also
help nucleate assembly of larger transcriptional complexes, in-
cluding the E-box-GATA DNA-binding complex shown. When
SSBPs are present at insufficient levels to interact with Ldb1,
RLIM promotes the ubiquitination of Ldb1 and LIM-only pro-
teins, targeting them for destruction in the 26S proteasome.
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sertion (Nishioka et al. 2005) provide support for this
notion and illustrate the consequences of unopposed
LIM protein and Ldb1 ubiquitination.
Although our studies focused on cellular differentia-
tion, several lines of evidence suggest they could also be
relevant to tumorigenesis. First, misexpression of LMO
genes is observed in multiple tumor types, including T-
cell acute lymphoblastic leukemia, neuroblastoma, and
carcinoma of the head and neck and breast (Valge-Archer
et al. 1998; Visvader et al. 2001; Ferrando et al. 2002;
Hacein-Bey-Abina et al. 2003; Mizunuma et al. 2003;
Aoyama et al. 2005), and overexpression of LMO pro-
teins in transgenic models has been shown to cause or
contribute to tumor development (Larson et al. 1994;
Chervinsky et al. 1999; Aoyama et al. 2005; Sum et al.
2005). Importantly, LMO4 and LDB1 protein levels are
concordantly up-regulated in human oral cavity carcino-
mas (Mizunuma et al. 2003), and high-level expression of
one or more SSBP genes was detected in a majority of
samples in a small series of carcinomas of the head and
neck (C. Chung and S.J. Brandt, unpubl.). In addition,
clonal retroviral insertions predicted to increase tran-
scription of these genes have been noted in all three Ssbp
loci in lymphoid leukemias in certain inbred mouse
strains (Mouse Retrovirus Tagged Cancer Gene Data-
base; http://rtcgd.ncifcrf.gov). However, SSBP2 expres-
sion was also found to be decreased in human myeloid
leukemias (Qian et al. 2002; Liang et al. 2005). We hy-
pothesize that altered expression of SSBPs, either in-
creased or decreased, would contribute to tumorigenesis
by disrupting the normal stoichiometry of important
LDB–LIM protein-containing complexes.
Materials and methods
Plasmid constructs
The P4.2 promoter-luciferase reporter plasmid pGL2-
P4.2p1700-Luc and expression vectors pcDNA3.1-Tal1,
pcDNA3.1-E47, pcDNA3.1-GATA-1, pEFIRES-Ldb1, pEFIRES-
Lmo2, pFlag-CMV5-SSBP2, and CMV-HA-ubiquitin have been
described (Xu et al. 2003; Liang et al. 2005). A cDNA for the
Ldb1 splice isoform Ldb1b lacking the LIM interaction domain
(Tran et al. 2006) was subcloned into pEFIRES-P. cDNAs encod-
ing Flag-tagged human SSBP2 and its 94 N-terminal amino acids
were amplified by PCR from pFlag-CMV5-SSBP2 and also sub-
cloned into pEFIRES-P. pEFIRES-SSBP2(51–94), pEFIRES-
SSBP2(95–261), and pEFIRES-Ldb1(214–223) were con-
structed using PCR as described (Imai et al. 1991). Plasmid
CMV6-XL4-RLIM was purchased from Origene. The full-length
human LMO4 coding sequence was amplified using RNA from
MCF-7 cells. cDNAs encoding RLIM, Ldb1, Ldb1(214–223),
and Lmo2 were obtained using PCR and subcloned into pTracer-
EF/V5-His (Invitrogen). The correct sequences of their inserts
and sizes of the proteins expressed from these plasmids were
both verified. The small interfering RNA (siRNA) target se-
quences, shown in the Supplemental Material, were selected
using siRNA Target Finder (http://www.ambion.com). Double-
stranded oligonucleotides comprised of 19-base-pair (bp) sense
and antisense sequences linked by a 9-bp loop were cloned into
pSilencer 4.1-CMV-puro (Ambion) to construct the shRNA ex-
pression vectors pSilencer-Ssbp2-A, pSilencer-Ssbp2-B, and pSi-
lencer-Ssbp2-D; pSilencer-Ssbp3-C; and pSilencer-EGFP. The
pSilencer-CMV-puro-Control vector was also from Ambion.
Cell culture and generation of short-term transductants
MEL and COS-7L cells were handled as described (Xu et al.
2003). CHO cells were transfected using the FuGENE 6 reagent
(Roche). For transient knockdown experiments, MEL cells were
transfected with shRNA expression vectors targeted to Ssbp2,
Ssbp3, EGFP, or a control sequence, transferred 15 h later to
medium containing 6 µg/mL puromycin and 1.8% DMSO, and
cultured for an additional 40 h. Viable cells enriched with Lym-
phoprep reagent (Axis-Shield) were used in the preparation of
nuclear extracts or incubated in medium containing 1.8%
DMSO for an additional 48 h before total cellular RNA was
prepared.
Generation of stable transductants
pEFIRES-SSBP2, pEFIRES-SSBP2(95–261), or parental vector
was introduced into MEL cells, and transductants were selected
with puromycin as described (Xu et al. 2003). Polyclonal popu-
lations of SSBP2(95–261)- and vector-transduced MEL cells
were used. Ten oligoclonal populations were derived for SSBP2-
transduced MEL cells, and three lines—O3, O4, and O6—were
used in the studies described. pSilencer-CMV-puro-Control or
the combination of pSilencer-Ssbp2-A and pSilencer-Ssbp2-B
was similarly handled. For Ssbp2 shRNA-transduced cells, nine
monoclonal populations were analyzed for Ssbp2 abundance,
and two lines were selected.
EMSA
Nuclear extracts from MEL and FVA cells were prepared, and
EMSA of DNA-binding activity was carried out as described (Xu
et al. 2003). Rabbit immunoglobulin and antibodies to Ldb1,
GATA-1, and SSBP2 have also been described (Xu et al. 2003;
Liang et al. 2005). Polyclonal antibody to the Flag epitope
(F7425) was purchased from Sigma. Details on the antibody to
SSBP3 will be published elsewhere.
Western blot and immunoprecipitation analyses
Western blot analysis was carried out as described (Xu et al.
2003). For immunoprecipitation, cells were extracted on ice in
50 mM Tris-HCl (pH 8.0), 150 mM NaCl, 1 mM EDTA, 1 mM
DTT, 1 mM NaVO4, 0.5% NP-40, and 10% glycerol. Immuno-
precipitated proteins were captured by Protein G-agarose and
washed three times with 50 mM Tris-HCl (pH 8.0), 150 mM
NaCl, and 0.1% NP-40, and specific proteins were identified by
Western blot analysis. In addition to the antibodies above, af-
finity-purified rabbit polyclonal antibody to Tal1 was prepared
as described (Kallianpur et al. 1994). Rabbit antibodies to
HDAC2 (sc-7899) and actin (sc-1615) were from Santa Cruz Bio-
technology, mouse monoclonal antibody to the V5 epitope
(catalog no. 46-0705) was from Invitrogen, sheep polyclonal an-
tibody to Lmo2 (ab16132) was from Abcam, and monoclonal
antibody to the HA epitope (MMS-101P) was from Covane.
Quantitative RT–PCR analysis
Total cellular RNA was prepared using RNeasy Midi reagents
(Qiagen), and residual genomic DNA was removed by DNase I
treatment (Ambion). One microgram of this RNA was then con-
verted to cDNA with the iScript cDNA Synthesis product (Bio-
Rad) and analyzed by real-time PCR using the iQ SYBR Green
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Supermix (Bio-Rad). Relative quantification of cDNAs used a
standard curve generated by serial dilution of cDNAs, and levels
of P4.2, -globin, RLIM, and Ldb1 mRNAs were normalized to
that of ribosomal S16. The sequences of the primers used in
PCR analysis are given in the Supplemental Material.
ChIP analysis
ChIP analysis was performed with an EZ ChIP kit (Upstate Bio-
technology), and immunoprecipitated DNA was analyzed by
real-time PCR using the iQ SYBR Green Supermix (Bio-Rad).
Levels of factor occupancy were determined by subtracting the
values obtained with normal IgG from those with the indicated
antibodies. The sequences of the primers used in the PCR analy-
sis are given in the Supplemental Material.
Protein turnover analysis
Transduced MEL cells were treated with 100 µM CHX for the
indicated times, and whole-cell extracts were subjected to West-
ern blot analysis.
In vivo ubiquitination assay
CHO cells were transfected with the indicated combinations of
expression plasmids for Ldb1, RLIM, SSBP2, and HA-ubiquitin.
Beginning 43 h after transfection, the proteasomal inhibitor
MG132 was added to the medium (25 µM), and the cells were
incubated for an additional 5 h. Whole-cell extracts were then
subjected to immunoprecipitation with antibodies to Ldb1 or
HA epitope, and specific proteins were identified by Western
blot analysis.
Deubiquitination assay
Flag-tagged SSBP2 protein was purified from SSBP2-transfected
CHO cells using the FLAG M purification kit (Sigma). Ubiqui-
tinated Ldb1 was immunoprecipitated from CHO cells that had
been transfected with Ldb1, RLIM, and HA-ubiquitin and
treated with MG132. Protein G beads loaded with ubiquitinated
Ldb1 were washed three times with 50 mM Tris-HCl (pH 8.0),
50 mM NaCl, and 0.1% NP-40, and twice with deubiquitination
buffer (50 mM Tris-HCl at pH 8.0, 50 mM NaCl, 1 mM EDTA,
10 mM DTT, 5% glycerol). Beads were incubated for 2 h at 37°C
in deubiquitination buffer containing 1000 ng of purified Flag-
SSBP2 protein or the same concentration of 3× Flag peptide as
described (Li et al. 2002). After extensive washing, captured pro-
teins were quantified by Western blot analysis with antibodies
to the HA and Flag epitopes.
Autoradiographic analysis
Band intensities on photographic film were quantified with NIH
Image software (version 1.62).
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